Bruker Corp
BRKR
Market Cap$10.19B
Close$
$35.29
52.5% downside
Current Fair Value
52.5% downsideOvervalued by 52.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.19 Billion |
|---|---|
| Enterprise Value | $10.98 Billion |
| Dividend Yield | $0.1996 (0.28%) |
| Earnings per Share | $2.9 |
| Beta | 1.03 |
| Outstanding Shares | 145,334,691 |
| Avg 30 Day Volume | 981,568 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 23.84 |
|---|---|
| PEG | 21.48 |
| Price to Sales | 3.72 |
| Price to Book Ratio | 8.26 |
| Enterprise Value to Revenue | 3.7 |
| Enterprise Value to EBIT | 22.6 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.93 |
Revenue Sources
No data
ESG Score
No data
About Bruker Corp
6,000 employees
CEO: Frank Laukien Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...